Top compounds associated with response to LRFN2


Feature Type Standardized
Nominal ANOVA
mRNA TAE684 GDSC1000 pan-cancer AAC -0.022 0.7
mRNA tanespimycin:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.013 0.7
mRNA triptolide CTRPv2 pan-cancer AAC -0.014 0.7
mRNA necrostatin-1 CTRPv2 pan-cancer AAC 0.015 0.7
mRNA Zebularine CTRPv2 pan-cancer AAC 0.014 0.7
mRNA PIK-93 CTRPv2 pan-cancer AAC -0.014 0.7
mRNA BIX02189 GDSC1000 pan-cancer AAC 0.013 0.7
mRNA tretinoin:carboplatin (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.014 0.7
mRNA EX-527 GDSC1000 pan-cancer AAC 0.014 0.7
mRNA JQ-1:UNC0638 (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.014 0.7
Download CSV